CA
NZ
UK
AU
IND
US
A Form 4 filed on August 11, 2026 discloses that Quentin S. Blackford, President and CEO of iRhythm Holdings, Inc. (NASDAQ:IRTC), acquired 48,534 shares of common stock upon vesting of performance restricted stock units and subsequently sold 26,859 shares to cover tax withholding obligations.
A Form 4 filed on August 11, 2026 reports that Patrick Michael Murphy, CBO and CLO of iRhythm Holdings, Inc. (NASDAQ:IRTC), acquired 13,589 shares of common stock upon vesting of performance RSUs on August 7, 2026, and subsequently sold 7,093 shares on August 10, …
Chad Patterson, Chief Commercial and Product Officer of iRhythm Holdings, Inc., filed a Form 4 on August 11, 2026, disclosing the acquisition of shares upon performance RSU vesting and a subsequent sale of shares to cover tax withholding obligations.
A Form 4 filed on August 11, 2026 discloses that Hong Q. Hou, President and CEO of Semtech Corp (NASDAQ:SMTC), disposed of 2,000 shares of common stock on August 7, 2026 pursuant to a pre-established Rule 10b5-1 trading plan.
Stephen J. Hill, Chief Operating Officer of Lyell Immunopharma, Inc., filed a statement of changes in beneficial ownership on August 11, 2026, reporting an automatic share sale on August 10, 2026, to cover tax obligations arising from the settlement of vested restricted stock units.
Patrick H. Hawkins, CEO and President of Hawkins Inc, filed a Form 4 on August 11, 2026, disclosing a disposition of 580 shares of common stock via gift on August 7, 2026, along with updated beneficial ownership totals.
A Statement of Changes in Beneficial Ownership was filed on August 11, 2026, reporting that Jeffrey Sine, a director of Arm Holdings PLC /UK (NASDAQ:ARM), transferred 9,572 American Depositary Shares to a charitable donor-advised fund on August 7, 2026.
Gary K. Lee, Chief Scientific Officer of Lyell Immunopharma, Inc. (NASDAQ:LYEL), filed a Form 4 on August 11, 2026, reporting an automatic sale of common stock on August 10, 2026, to cover tax withholding obligations arising from the settlement of vested restricted stock units.
A Form 4 filed on August 11, 2026, reports that Veronica Sanchez Bulis, VP and Corporate Controller of Lyell Immunopharma, Inc. (NASDAQ:LYEL), disposed of 621 shares of common stock on August 10, 2026, to cover tax withholding obligations from the settlement of vested restricted …
A Form 4 filed with the SEC on August 11, 2026 reports that Amber Lynne Cottle, a director of Primerica, Inc. (NYSE:PRI), disposed of 279 shares of common stock on August 11, 2026.
Please wait processing your request...